Phase1b/2 Trial Of AZA + APG1252 In Patients With High-Risk AML
Clinical trial NCT07508982 · RECRUITING
Trial details
- NCT number
- NCT07508982
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-22
- Primary completion
- 2029-12-12
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.